Additional information
Yellow Powder
168329-48-4
ACI-020805
280.1-282.3°C
C9H8BrN5
266.1
Ambient
2-8°C
ocular hypertension
Pharmaceutical Impurity Standards
1-(5-bromoquinoxalin-6-yl)guanidine
2-(5-Bromoquinoxalin-6-yl)guanidine
N-(5-Bromo-6-quinoxalinyl)quanidine





![N-METHYL REGADENOSON (25 mg) (1-[6-amino-9-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]purin-2-yl]-N,N-dimethylpyrazole-4-carboxamide )](https://analyticachemie.in/wp-content/uploads/uspimage-1.jpg)